Rhode Island
Phase 1 cancer trials in Rhode Island
20 Phase 1 cancer studies are recruiting participants at sites in 2 cities across Rhode Island as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Rhode Island city with a recruiting study
By research area: Lung Cancer (6), Lymphoma (6), Prostate Cancer (5), Breast Cancer (3).
Providence (19), East Providence (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Rhode Island
Basic details from each study's public record (the 12 most recently updated of 20). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Recruiting in
- Providence
- Registry record
- NCT05579366 · updated
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Providence
- Registry record
- NCT06084481 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Rhode Island on ClinicalTrials.gov.
Lung cancer: recently updated in Rhode Island
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Providence
- Registry record
- NCT06996782 · updated
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bicara Therapeutics
- Recruiting in
- Providence
- Registry record
- NCT04429542 · updated
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Phase 1/2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Providence
- Registry record
- NCT05797168 · updated
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Recruiting in
- East Providence
- Registry record
- NCT06750185 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Rhode Island on ClinicalTrials.gov.
Prostate cancer: recently updated in Rhode Island
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Recruiting in
- Providence
- Registry record
- NCT03972657 · updated
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Recruiting in
- Providence
- Registry record
- NCT05519449 · updated
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 to 130
- Male participants
- Sponsor
- AstraZeneca
- Recruiting in
- Providence
- Registry record
- NCT07181161 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Rhode Island on ClinicalTrials.gov.
Lymphoma: recently updated in Rhode Island
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Providence
- Registry record
- NCT04726241 · updated
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Providence
- Registry record
- NCT06564038 · updated
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Imugene Limited
- Recruiting in
- Providence
- Registry record
- NCT03666000 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Rhode Island on ClinicalTrials.gov.
Ask about studies in Rhode Island
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections